Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ACTO LAUNCHES CXZONE: THE FIRST AI-SIMULATED ROLEPLAY SOLUTION BUILT EXCLUSIVELY FOR PHARMA FIELD PROFESSIONALS AND INTEGRATED WITH VEEVA PROMOMATS AND MEDCOMMS
  • USA - Deutsch
  • USA - español
  • USA - English
  • USA - Français

ACTO: AI-Powered Intelligent Field Excellence for Life Sciences--ensuring field reps are competent, confident, and credible in face-to-face HCP interactions. (CNW Group/ACTO Technologies, Inc.)

News provided by

ACTO Technologies, Inc.

Jul 24, 2025, 08:30 ET

Share this article

Share toX

Share this article

Share toX

A Specialized Practice Environment to Sharpen Clinical Fluency, Master Product Messaging, and Drive Continuous Improvement Through a Gamified Experience

TORONTO and NEW YORK, July 24, 2025 /PRNewswire/ - ACTO, a leader in AI-first commercial learning, enablement, and customer engagement solutions for life sciences and a Veeva Product Partner and member of the Veeva AI Partner Program, today announced the launch of CxZone, the first and only AI-simulated roleplay solution exclusively designed for pharmaceutical field professionals and integrated with Veeva PromoMats and MedComms. Built to improve customer experience (CX), CxZone helps field teams master clinical conversations in a fast, flexible, and feedback-rich environment tailored to the unique nuances of the industry.

Continue Reading
Announcing CxZone, the first and only AI-simulated roleplay solution exclusively designed for pharmaceutical field professionals and integrated with Veeva PromoMats and MedComms. CxZone helps field teams master clinical conversations in a fast, flexible, and feedback-rich environment tailored to the unique nuances of the industry.
CxZone gives field reps and MSLs judgment-free, on-demand practice with instant feedback aligned to a company’s unique sales process and coaching models. (CNW Group/ACTO Technologies, Inc.)
Announcing CxZone, the first and only AI-simulated roleplay solution exclusively designed for pharmaceutical field professionals and integrated with Veeva PromoMats and MedComms. CxZone helps field teams master clinical conversations in a fast, flexible, and feedback-rich environment tailored to the unique nuances of the industry. CxZone gives field reps and MSLs judgment-free, on-demand practice with instant feedback aligned to a company’s unique sales process and coaching models. (CNW Group/ACTO Technologies, Inc.)

CxZone gives field reps and MSLs judgment-free, on-demand practice with instant feedback aligned to a company's unique sales process and coaching models. Unlike generic AI roleplay tools, CxZone goes beyond basic sales skill development, focusing on what matters most in HCP conversations—clinical fluency and product messaging. Practice scenarios in CxZone can be built around content auto-synced with Veeva PromoMats and MedComms, ensuring field professionals always practice with current, approved materials. This drives usage of promotional materials, scientific articles, clinical study reports, and other resources that enhance the HCP experience.

"We're thrilled about CxZone as it mirrors the dynamic nature of our field teams' conversations with Eye Care Professionals," said Sheryl Bisson, Senior Manager, Training & Development at Johnson & Johnson Vision. "It will enhance our reps' confidence and clinical skills, allowing them to excel in every interaction. This could truly be a game-changer."

CxZone is built on ACTO's proprietary Empathetic AI engine, which makes the AI-simulated HCP interaction realistic and personal. In CxZone, field professionals can model their practice avatar to match the type of HCP, therapeutic area, and mood that matches their target HCP.

CxZone also incorporates insight about your field professionals, such as their role, product set, and competency strengths and weaknesses, so HCP avatar questions and responses are hyper-relevant to elevate rep performance.

As part of its upcoming roadmap, ACTO will soon introduce My HCP, a powerful new CxZone capability that brings a deeper level of personalization to simulations. By integrating unique HCP data and insights from Veeva Vault CRM—such as prescribing behavior, hospital affiliations, patient volume estimates, and speaker program participation—My HCP will allow field users to practice with realistic digital twins of their actual customers. This personalization is further enhanced by enabling reps and MSLs to capture the unique nuances of each HCP relationship. Combined with behavioral data like content engagement, sampling history, and call notes from Veeva Vault CRM, My HCP will simulate next-best conversations with unprecedented context and realism.

CxZone's key differentiators include:

  • True-to-life HCP avatars that match the profile of your reps' customers, convey the typical time pressure of interactions, and challenge reps with realistic clinical questions and responses

  • Tailored AI simulations that align with a company's unique training methodology, sales process, and coaching models

  • Specialized practice zones focused on clinical fluency and product messaging, powered by the latest MLR-approved content from Veeva PromoMats and MedComms

  • Gamified experience that automates instant measurement scores, practice streaks, and individual performance trends to drive engagement

  • Built for compliance — SOC 2 Type II certified, ensuring data is secure and controlled and validated to comply with FDA 21 CFR Part 11 to meet the required regulatory standards for security, integrity, and reliability

"In life sciences, the success of a new therapy hinges on how effectively reps, MSLs and clinical specialists engage the HCP, especially in complex therapeutic areas," said Parth Khanna, CEO of ACTO. "With CxZone, we set out to reimagine roleplay from the ground up, addressing real-world industry challenges like limited HCP access, inconsistent coaching, and field resistance to traditional methods. The result is the industry's only gamified, AI-driven roleplay solution integrated with Veeva. With CxZone, it's not just about practicing a pitch; it's about building clinical fluency, anticipating real-world objections, and speaking the language of medicine with clarity and confidence. HCP interactions are more valuable, and trust is built. CxZone is truly a breakthrough moment for customer experience in life sciences."

CxZone is now available to life sciences companies looking to improve the customer experience and elevate their field force performance in the moments that matter most.

For more information or to request a demo, visit www.acto.com/CxZone.

Visit www.acto.com, or follow ACTO on LinkedIn for the latest company announcements and news.

About ACTO

ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and Marketing teams improve customer engagement and brand performance. With ACTO, biopharma companies can ensure field professionals are always competent, confident, and credible in face-to-face HCP interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness. As a validated platform compliant with FDA 21 CFR Part 11 and SOC 2 Type II certified, ACTO is the trusted partner for intelligent field excellence in the life sciences industry.

SOURCE ACTO Technologies, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

ACTO LANCE CXZONE : LA PREMIÈRE SOLUTION DE JEU DE RÔLE SIMULÉE PAR L'INTELLIGENCE ARTIFICIELLE, CONÇUE EXCLUSIVEMENT POUR LES PROFESSIONNELS DE L'INDUSTRIE PHARMACEUTIQUE ET INTÉGRÉE À VEEVA PROMOMATS ET MEDCOMMS

ACTO LANCE CXZONE : LA PREMIÈRE SOLUTION DE JEU DE RÔLE SIMULÉE PAR L'INTELLIGENCE ARTIFICIELLE, CONÇUE EXCLUSIVEMENT POUR LES PROFESSIONNELS DE L'INDUSTRIE PHARMACEUTIQUE ET INTÉGRÉE À VEEVA PROMOMATS ET MEDCOMMS

ACTO, un leader en matière de solutions d'apprentissage commercial, d'habilitation et d'engagement des clients axées sur l'IA pour les sciences de la ...

ACTO BRINGT CXZONE AUF DEN MARKT: DIE ERSTE KI-SIMULIERTE ROLLENSPIEL-LÖSUNG, DIE EXKLUSIV FÜR PHARMA-AUSSENDIENSTMITARBEITER ENTWICKELT UND IN VEEVA PROMOMATS UND MEDCOMMS INTEGRIERT WURDE

ACTO BRINGT CXZONE AUF DEN MARKT: DIE ERSTE KI-SIMULIERTE ROLLENSPIEL-LÖSUNG, DIE EXKLUSIV FÜR PHARMA-AUSSENDIENSTMITARBEITER ENTWICKELT UND IN VEEVA PROMOMATS UND MEDCOMMS INTEGRIERT WURDE

ACTO, ein führender Anbieter von KI-gestützten kommerziellen Lern-, Befähigungs- und Kundenbindungslösungen für die Biowissenschaften und ein...

More Releases From This Source

Explore

Computer Software

Computer Software

Computer Software

Computer Software

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.